+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Male Infertility Treatment Market by Techniques - Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2022

  • ID: 4853578
  • Report
  • February 2017
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

The report covers forecast and analysis for the male infertility treatment market on a global and regional level. The study provides historic data of 2014 along with a forecast from 2017 to 2022 based on revenue (USD Million). The study includes drivers and restraints for the male infertility treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the male infertility treatment market on a global level.

This report offers comprehensive coverage on global male infertility treatment market along with, market trends, drivers, and restraints of male infertility treatment market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the male infertility treatment market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts.

The study provides a decisive view on the male infertility treatment market by segmenting the market based on technique and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2022. The technique market covered under this study includes DNA fragmentation, oxidative stress analysis, sperm penetration, microscopic analysis, sperm agglutination and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further segmented into US, UK, Germany, France, Japan, China, India, and Brazil.  

Key players of male infertility treatment market included in the report are ASKA Pharmaceutical Co. Ltd, ZydusCadila Healthcare Limited, Access Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., Pantarhei Bioscience B, Cordex Pharma, Inc., Merck Serono, Halotech DNA SL, SCSA diagnostics, Andrology Solutions.

This report segments the male infertility treatment market are follows:

Male Infertility Treatment Market: Techniques Segment Analysis

  • DNA fragmentation
  • Oxidative stress analysis
  • Sperm penetration
  • Microscopic analysis
  • Sperm agglutination
  • Others

Male Infertility Treatment Market: Regional Segment Analysis

  • North America
  • U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • The Middle East and Africa
Note: Product cover images may vary from those shown
2 of 2
  • Chapter 1. Introduction
    • 1.1. Report Description And Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Male Infertility Treatment Market, 2014 – 2022 (USD Million)
    • 2.2. Global Male Infertility Treatment Market: Snapshot
  • Chapter 3. Male Infertility Treatment – Market Dynamics
    • 3.1. Introduction
    • 3.2. Value Chain Analysis
    • 3.3. Market Drivers
      • 3.3.1. Global Male Infertility Treatment Market Drivers: Impact Analysis
      • 3.3.2. Obesity
      • 3.3.3. Torpid lifestyle
    • 3.4. Market Restraints
      • 3.4.1. Global Male Infertility Treatment Market Restraints: Impact Analysis
      • 3.4.2. Lack Of Education, discontinuation of treatment
    • 3.5. Opportunities
      • 3.5.1. Covering Untapped Market
    • 3.6. Porter’s Five Forces Analysis
      • 3.6.1. Bargaining Power Of Suppliers
      • 3.6.2. Bargaining Power Of Buyers
      • 3.6.3. Threat From New Entrants
      • 3.6.4. Threat From New Substitutes
      • 3.6.5. Degree Of Competition
    • 3.7. Market Attractiveness Analysis
      • 3.7.1. Market Attractiveness Analysis, By Techniques Segment
      • 3.7.2. Market Attractiveness Analysis, By Regional Segment
  • Chapter 4. Global Male Infertility Treatment Market – Competitive Landscape
    • 4.1. Company Market Share, 2015 (Subject To Data Availability)
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Type Launch
      • 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
      • 4.2.4. Research And Development, Regional Expansion
    • 4.3. Type Portfolio
  • Chapter 5. Global Male Infertility Treatment Market – Techniques Analysis
    • 5.1. Global Male Infertility Treatment Market: Techniques Overview
      • 5.1.1. Global Male Infertility Treatment Market Revenue Share, By Techniques , 2016 And 2022
    • 5.2. DNA Fragmentation
      • 5.2.1. Global DNA Fragmentation Market, 2014 – 2022 (USD Million)
    • 5.3. Oxidative Stress Analysis
      • 5.3.1. Global Oxidative Stress Analysis Market, 2014 – 2022 (USD Million)
    • 5.4. Sperm Penetration
      • 5.4.1. Global Sperm Penetration Market, 2014 – 2022 (USD Million)
    • 5.5. Microscopic Analysis
      • 5.5.1. Global Microscopic Analysis Market, 2014 – 2022 (USD Million)
    • 5.6. Sperm Agglutination
      • 5.6.1. Global Sperm Agglutination Market, 2014 – 2022 (USD Million)
    • 5.7. Others
      • 5.7.1. Global Other Male Infertility Treatment Market, 2014 – 2022 (USD Million)
  • Chapter 6. Global Male Infertility Treatment Market – Regional Segment Analysis
    • 6.1. Global Male Infertility Treatment Market: Regional Overview
      • 6.1.1. Global Male Infertility Treatment Market Revenue Share, By Region, 2016 And 2022
    • 6.2. North America
      • 6.2.1. North America Male Infertility Treatment Market Revenue, By Techniques , 2014 – 2022 , (USD Million)
      • 6.2.2. U.S.
        • 6.2.2.1. U.S. Male Infertility Treatment Market Revenue, By Techniques , 2014 – 2022 (USD Million)
    • 6.3. Europe
      • 6.3.1. Europe Male Infertility Treatment Market Revenue, By Techniques , 2014 – 2022 (USD Million)
      • 6.3.2. Germany
        • 6.3.2.1. Germany Male Infertility Treatment Market Revenue, By Techniques , 2014 – 2022, (USD Million)
      • 6.3.3. France
        • 6.3.3.1. France Male Infertility Treatment Market Revenue, By Techniques , 2014 – 2022, (USD Million)
      • 6.3.4. UK
        • 6.3.4.1. UK Male Infertility Treatment Market Revenue, By Techniques , 2014 – 2022 (USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Male Infertility Treatment Market Revenue, By Techniques , 2014 – 2022 (USD Million)
      • 6.4.2. China
        • 6.4.2.1. China Male Infertility Treatment Market Revenue, By Techniques , 2014 – 2022 (USD Million)
      • 6.4.3. Japan
        • 6.4.3.1. Japan Male Infertility Treatment Market Revenue, By Techniques , 2014 – 2022 (USD Million)
      • 6.4.4. India
        • 6.4.4.1. India Male Infertility Treatment Market Revenue, By Techniques , 2014 – 2022 (USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America Male Infertility Treatment Market Revenue, By Techniques , 2014 – 2022 (USD Million)
      • 6.5.2. Brazil
        • 6.5.2.1. Brazil Male Infertility Treatment Market Revenue, By Techniques , 2014 – 2022 (USD Million)
    • 6.6. Middle East And Africa
      • 6.6.1. Middle East And Africa Male Infertility Treatment Market Revenue, By Techniques , 2014 – 2022 (USD Million)
  • Chapter 7. Company Profile
    • 7.1. ASKA Pharmaceutical Co. Ltd
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Zydus Cadila Healthcare Limited,
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Access Pharmaceuticals, Inc.
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. Intas Pharmaceuticals Ltd.
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Pantarhei Bioscience B
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Developments
    • 7.6. Cordex Pharma, Inc.
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Developments
    • 7.7. Merck Serono
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Developments
    • 7.8. Halotech DNA SL
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Developments
    • 7.9. SCSA diagnostics
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Developments
    • 7.10. Andrology Solutions
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Product Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Developments
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll